×
About 318 results

ALLMedicine™ Alopecia Totalis Center

Research & Reviews  88 results

Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
https://www.mdedge.com/dermatology/article/256923/hair-nails/unique-treatment-alopecia-areata-combining-epinephrine
Eugeniu Stratulat, MD, Terri Shih, BS et. al.

Aug 9th, 2022 - Alopecia areata (AA) is an autoimmune disorder characterized by transient hair loss with preservation of the hair follicle (HF). The lifetime incidence risk of AA is approximately 2%,1 with a mean age of onset of 25 to 36 years and with no clinica.

JAAD Game Changers: Topical 2% tofacitinib for children with alopecia areata, alopecia ...
https://doi.org/10.1016/j.jaad.2022.07.033
Journal of the American Academy of Dermatology; Cotton CH

Aug 7th, 2022 - JAAD Game Changers: Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.|2022|Cotton CH,|

Long-Term Efficacy of Dupilumab in Alopecia Areata.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235915
The American Journal of Case Reports; Kulkarni M, Rohan CA et. al.

Jun 22nd, 2022 - BACKGROUND Dupilumab is a relatively new immune-modulating drug that has transformed the way clinicians treat common immunologic conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. Blocking signaling m...

Alopecia Areata
https://emedicine.medscape.com/article/1069931-overview

Jun 13th, 2022 - Practice Essentials Alopecia areata is a recurrent nonscarring type of hair loss that can affect any hair-bearing area and can manifest in many different patterns. Although it is a benign condition and most patients are asymptomatic, it can cause ...

Alopecia Areata Clinical Presentation
http://emedicine.medscape.com/article/1069931-clinical

Jun 13th, 2022 - History The natural history of alopecia areata is unpredictable. Extreme variations in duration and extent of the disease occur from patient to patient. Alopecia areata most often is asymptomatic, but some patients (14%) experience a burning sensa...

see more →

Clinicaltrials.gov  14 results

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04238091

Mar 21st, 2022 - Alopecia areata (AA) is an autoimmune condition resulting in chronic and relapsing hair loss. AA patchy is associated with well-circumscribed patches of hair loss, commonly on the scalp or face, while alopecia totalis (AT) and alopecia universalis...

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04011748

Jun 30th, 2021 - Alopecia areata (AA) is a common autoimmune disease that results in loss of body hair in varying degrees. The condition is estimated to affect more than 6.5 million people in the United States alone (naaf.org), with a worldwide prevalence of 0.1% ...

Fecal Transplant for Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04833179

Apr 6th, 2021 - Alopecia areata (AA) is a common autoimmune disease that triggers non scarring hair loss in different severities. Usually the hair loss will be contained to the scalp and / or beard, but in some cases, there will be total hair loss from the entire...

A Study of Secukinumab for the Treatment of Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT02599129

Mar 11th, 2021 - Alopecia areata is a medical condition, in which the hair falls out in patches. The hair can fall out on the scalp or elsewhere on the face and body. Alopecia areata is an autoimmune skin disease, which means that the immune system is recognizing ...

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
https://clinicaltrials.gov/ct2/show/NCT03759340

Oct 6th, 2020 - This Phase 2, multicenter, open-label study will evaluate the safety, tolerability, efficacy, and durability of efficacy of ATI-502 Topical Solution, 0.46% for the treatment of alopecia areata (AA), alopecia universalis (AU) and alopecia totalis (...

see more →

News  25 results

Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
https://www.mdedge.com/dermatology/article/256923/hair-nails/unique-treatment-alopecia-areata-combining-epinephrine
Eugeniu Stratulat, MD, Terri Shih, BS et. al.

Aug 9th, 2022 - Alopecia areata (AA) is an autoimmune disorder characterized by transient hair loss with preservation of the hair follicle (HF). The lifetime incidence risk of AA is approximately 2%,1 with a mean age of onset of 25 to 36 years and with no clinica.

Focal hair loss
https://www.mdedge.com/familymedicine/article/254363/dermatology/focal-hair-loss
MDedge Family Medicine;

May 5th, 2022 - The findings of smooth, round alopecia occurring rapidly without associated scarring, pain, or itching, is consistent with the diagnosis of alopecia areata. Alopecia areata is a common autoimmune disease caused by T lymphocytes targeting hair foll.

Review looks at natural course of alopecia areata in young children
https://www.mdedge.com/dermatology/article/208895/pediatrics/review-looks-natural-course-alopecia-areata-young-children
Jake Remaly

Sep 26th, 2019 - Most children who develop alopecia areata before age 4 years have mild disease with less than 50% hair loss, and present between ages 2 and 4, according to a retrospective chart review of 125 children. Almost 90% of the children presented between.

Another JAK Inhibitor Shows Promise for Alopecia Areata
https://www.medscape.com/viewarticle/910163

Mar 11th, 2019 - The Janus kinase (JAK) inhibitor CTP-543 (Concert Pharmaceuticals) is effective for the treatment of moderate to severe alopecia areata, according to interim results from a phase 2a randomized safety and efficacy study (NCT03137381). "We've identi...

The Case of the Disappearing Eyebrows
https://www.mdedge.com/clinicianreviews/article/195335/dermatology/case-disappearing-eyebrows/page/0/1?channel=203

Feb 28th, 2019 - DISCUSSION This case illustrates several variants of an extremely common condition: alopecia areata (AA), literally translated as “hair loss confined to a particular localized area or areas. ” Although AA is more common in adults, it often affects.

see more →